Insider Transactions in Q4 2024 at Prestige Consumer Healthcare Inc. (PBH)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 19
2024
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
10,875
-1.67%
|
$891,750
$82.6 P/Share
|
|
Nov 19
2024
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,875
+1.64%
|
$609,000
$56.65 P/Share
|
|
Nov 18
2024
|
Ronald M. Lombardi Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
82,237
-11.32%
|
$6,743,434
$82.54 P/Share
|
|
Nov 18
2024
|
Ronald M. Lombardi Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
82,237
+10.14%
|
$4,605,272
$56.65 P/Share
|
|
Nov 12
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
SELL
Open market or private sale
|
Direct |
9,885
-20.46%
|
$800,685
$81.96 P/Share
|
|
Nov 12
2024
|
Mary Beth Fritz SVP Quality & Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
9,885
+16.83%
|
$464,595
$47.23 P/Share
|
|
Nov 12
2024
|
Adel Mekhail EVP, Marketing & Sales |
SELL
Open market or private sale
|
Direct |
9,063
-33.04%
|
$743,166
$82.0 P/Share
|
|
Nov 12
2024
|
Adel Mekhail EVP, Marketing & Sales |
BUY
Exercise of conversion of derivative security
|
Direct |
5,565
+16.87%
|
$244,860
$44.33 P/Share
|
|
Nov 12
2024
|
Christine Sacco Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
24,686
-45.04%
|
$2,024,252
$82.01 P/Share
|
|
Nov 12
2024
|
Christine Sacco Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,686
+31.05%
|
$740,580
$30.56 P/Share
|
|
Nov 12
2024
|
William P'Pool Officer |
SELL
Open market or private sale
|
Direct |
8,987
-30.94%
|
$727,947
$81.85 P/Share
|